ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,57
-0,56%
Dow Jones
39 150,33
0,04%
DAX
18 163,52
-0,41%
Brent Oil
84,39
0,00%
Bitcoin
64 444,63
0,31%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sienna Biopharmaceuticals Inc (SNNA)

  7. Sienna Biopharmaceuticals Inc (SNNA) Actualités

SNNA

Sienna Biopharmaceuticals (SNNA)

Sienna Biopharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SNNA
DateHeureSourceTitreSymboleSociété
07/02/202017h32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNNASienna Biopharmaceuticals Inc
05/02/202016h47Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:SNNASienna Biopharmaceuticals Inc
09/01/202014h00PR Newswire (US)Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna BiopharmaceuticalsNASDAQ:SNNASienna Biopharmaceuticals Inc
17/12/201912h00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201922h46Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201922h40Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201922h36Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201912h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNNASienna Biopharmaceuticals Inc
14/11/201922h05GlobeNewswire Inc.Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding ProceduresNASDAQ:SNNASienna Biopharmaceuticals Inc
14/11/201914h30GlobeNewswire Inc.Sienna Biopharmaceuticals Announces Successful Appeal of Nasdaq Delisting NoticeNASDAQ:SNNASienna Biopharmaceuticals Inc
12/11/201922h42Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNNASienna Biopharmaceuticals Inc
07/10/201914h30GlobeNewswire Inc.Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove L...NASDAQ:SNNASienna Biopharmaceuticals Inc
04/10/201920h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNNASienna Biopharmaceuticals Inc
17/09/201914h30GlobeNewswire Inc.Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection ProceedingNASDAQ:SNNASienna Biopharmaceuticals Inc
05/08/201915h05GlobeNewswire Inc.Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic AlternativesNASDAQ:SNNASienna Biopharmaceuticals Inc
20/06/201915h05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare ConferenceNASDAQ:SNNASienna Biopharmaceuticals Inc
10/06/201915h05GlobeNewswire Inc.Sienna Biopharmaceuticals Announces Late-Breaking Oral Presentation of Phase 2b Trial Results of its Topical, Non-Steroidal T...NASDAQ:SNNASienna Biopharmaceuticals Inc
21/05/201915h05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at Dermatology Drug Development Summit EuropeNASDAQ:SNNASienna Biopharmaceuticals Inc
14/05/201915h05GlobeNewswire Inc.Sienna Biopharmaceuticals Announces SNA-120 (0.05%) Biopsy Data Demonstrate Positive Impact on Key Inflammatory Cytokines, in...NASDAQ:SNNASienna Biopharmaceuticals Inc
09/05/201915h05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at BAML Health Care ConferenceNASDAQ:SNNASienna Biopharmaceuticals Inc
08/05/201922h05GlobeNewswire Inc.Sienna Biopharmaceuticals Reports First Quarter 2019 Financial ResultsNASDAQ:SNNASienna Biopharmaceuticals Inc
11/04/201914h07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/04/201914h03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNNASienna Biopharmaceuticals Inc
03/04/201923h25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNNASienna Biopharmaceuticals Inc
21/03/201921h05GlobeNewswire Inc.Sienna Biopharmaceuticals Promotes Alexander Azoy to Chief Financial Officer and Appoints Sean Andrews to Leadership Team as ...NASDAQ:SNNASienna Biopharmaceuticals Inc
14/03/201914h19Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNNASienna Biopharmaceuticals Inc
14/03/201914h17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNNASienna Biopharmaceuticals Inc
14/03/201914h05GlobeNewswire Inc.Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial ResultsNASDAQ:SNNASienna Biopharmaceuticals Inc
06/03/201922h41Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:SNNASienna Biopharmaceuticals Inc
05/03/201915h05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at Cowen and Company Health Care ConferenceNASDAQ:SNNASienna Biopharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNNA

Dernières Valeurs Consultées

NYSE
KO
Coca Cola
EU
LR
Legrand
EU
AI
Air Liquide
EU
RI
Pernod Ricard
EU
ML
Michelin
EU
PX4
SBF 120
NASDAQ
AAPL
Apple
COIN
BTCUSD
Bitcoin
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
USI
USTECH100
US Tech 100
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés